MENU
+Compare
MGX
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$2.29
Change
-$0.01 (-0.43%)
Capitalization
86.33M

MGX Metagenomi Forecast, Technical & Fundamental Analysis

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more

MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MGX with price predictions
Sep 25, 2025

MGX in upward trend: price rose above 50-day moving average on September 18, 2025

MGX moved above its 50-day moving average on September 18, 2025 date and that indicates a change from a downward trend to an upward trend. In of 7 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 15, 2025. You may want to consider a long position or call options on MGX as a result. In of 21 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MGX just turned positive on September 08, 2025. Looking at past instances where MGX's MACD turned positive, the stock continued to rise in of 13 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for MGX crossed bullishly above the 50-day moving average on September 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where MGX advanced for three days, in of 69 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MGX moved out of overbought territory on September 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator moved out of overbought territory. In of the 5 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 10 cases where MGX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MGX broke above its upper Bollinger Band on September 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MGX entered a downward trend on September 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.441) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.528) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MGX is expected to report earnings to rise 48.15% to -80 cents per share on November 12

Metagenomi MGX Stock Earnings Reports
Q3'25
Est.
$-0.80
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.40
Q3'24
Beat
by $0.24
The last earnings report on August 12 showed earnings per share of -54 cents, beating the estimate of -72 cents. With 506.12K shares outstanding, the current market capitalization sits at 86.33M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
236
Web
https://www.metagenomi.co
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAORF2.250.17
+8.43%
Mandarin Oriental International Ltd.
KMGH0.01N/A
N/A
Kemiao Garment Holding Group
ENQUF0.16N/A
N/A
Enquest Plc,
LBGUF45.79N/A
N/A
LE Lundbergfoeretagen AB
HYEX1.71N/A
N/A
HEALTHY EXTRACTS INC.

MGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with QURE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+10.05%
QURE - MGX
45%
Loosely correlated
+10.84%
KOD - MGX
42%
Loosely correlated
+1.23%
SABS - MGX
36%
Loosely correlated
-2.78%
BEAM - MGX
34%
Loosely correlated
-2.12%
CDXS - MGX
34%
Loosely correlated
-3.23%
More